An interventional study of High intensity resistance training and Low intensity resistance training combined with blood flow restriction in Rheumatoid Arthritis, sponsored by Federal University of Rio Grande do Sul. Recruiting at 1 site in Brazil. Open to female participants aged 45 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-05-22.
Sponsored by Federal University of Rio Grande do Sul · Not applicable, Interventional, and Treatment
Rheumatoid arthritis (RA) patients showed systemic manifestations that may lead to a reduction in muscle strength, muscle mass and, consequently, to a reduction in physical function. On the other hand, high intensity resistance training (HIRT) are able to improve muscle strength and muscle mass in RA without affecting the disease course. However, due to the articular manifestations caused by this disease, these patients may present intolerance to HIRT. Thus, the low intensity resistance training with blood flow restriction (TBFR) may be a new training strategy for these populations. In this sense, the investigators speculate that TBFR could be beneficial in RA patients, as well as, HIRT.
3,554 studies on the registry are indexed under Arthritis; 317 are open to participants now.
This study's planned enrollment of 28 is below the median of 90 across 2,377 interventional studies indexed under Arthritis.
Browse Arthritis studies →Federal University of Rio Grande do Sul is the lead sponsor of 118 studies on the registry; 20 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: High intensity resistance training
Other: Low intensity resistance training combined with blood flow restriction
Twelve weeks of resistance training twice a week.
Twelve weeks of resistance training with blood flow restriction twice a week.
Muscle strength
1 maximum repetition test.
Time frame: Twelve weeks
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Federal University of Rio Grande do Sul